Our purpose
Modern medicine is advancing rapidly, yet too many people still die of cancer, drug-resistant bacteria, and other infectious diseases. The demand for new, efficient drugs has never been higher and will only grow. Every day, our AI-Immunology™ platform is bringing us closer to a future where we will be able to treat a wide range of critical diseases in a targeted, patient-specific way. We see an immense market for new, efficient, and personalized drugs, as well as a substantial way to improve patients’ quality of life. This is why our purpose is: Decoding the human immune system to develop novel vaccines for cancer and infectious diseases with our AI-Immunology™ platform.